BRETT PAUL GIROIR, MD
Medical Practice at Harry Hines Blvd, Dallas, TX

License number

Texas H2404

Personal information

See more information about BRETT PAUL GIROIR at radaris.com

Name

Address

Phone

Brett Giroir

6231 Pemberton Dr, Dallas, TX 75230

Brett P Giroir

14141 Meandering Way, Dallas, TX 75254

(972) 484-6531
(972) 980-8059

Brett P Giroir

5322 Fleetwood Oaks St, Dallas, TX 75235

Brett P Giroir

6231 Pemberton Dr, Dallas, TX 75230

(214) 987-3438

Professional information

Macrophage Migration Inhibitory Factor As A Marker For Cardiovascular Risk

US Patent:

7445886, Nov 4, 2008

Filed:

Sep 10, 2003

Appl. No.:

10/660301

Inventors:

Brett P. Giroir - Dallas TX, US
Monty S. Willis - Dallas TX, US
Timothy S. Church - Dallas TX, US

Assignee:

Board of Regents, The University of Texas System - Austin TX

International Classification:

G01N 33/53, C12Q 1/00, C07K 1/00

US Classification:

435 4, 435 71

Abstract:

Macrophage migration inhibitory factor (MIF) is a clinically useful biochemical marker of cardiovascular risk. Risk assessment includes the step of detecting in the blood of a person MIF concentration as a marker of cardiovascular risk for the person. The method may further comprise the step of assigning to the person a cardiovascular risk metric proportional to the MIF concentration, and/or prescribing for the person a cardiovascular treatment modality in accordance with the MIF concentration. The method is useful as a primary screen, and may be used in conjunction with or as a substitute for additional tests, such as a stress test, CRP assay, LDL assay, etc. The detecting step may be repeated over time intervals and/or treatment to monitor change in cardiovascular risk for the person over time and/or treatment.

Dr. Brett P Giroir, Dallas TX - MD (Doctor of Medicine)

Specialties:

Pediatric Critical Care Medicine

Address:

5323 Harry Hines Blvd, Dallas 75390
(214) 645-0624 (Phone), (214) 645-0078 (Fax)
TEXAS A&M UNIVERSITY HEALTH SCIENCE CENTER
301 Tarrow St SUITE 7TH, College Station 77840
(979) 458-7240 (Phone), (979) 458-7202 (Fax)

Certifications:

Pediatric Critical Care Medicine, 2002, Pediatrics, 1998

Awards:

Healthgrades Honor Roll

Languages:

English

Education:

Medical School
University of Texas Southwestern Medical Center At Dallas
Graduated: 1986
Dallas Co Hp Parkland Mem
University Tx Southwestern Med School

Method Of Treating Chronic Cardiac Disease

US Patent:

6509317, Jan 21, 2003

Filed:

Jan 21, 2000

Appl. No.:

09/488979

Inventors:

Brett P. Giroir - Dallas TX
Patrick J. Scannon - San Francisco CA

Assignee:

Board of Regents, the University of Texas System - Austin TX
Xoma Technology Ltd. - Berkeley CA

International Classification:

A61K 3816

US Classification:

514 12, 514 2, 514 21

Abstract:

New therapeutic uses for BPI protein products that involve treatment of chronic cardiac disease.

Therapeutic Uses Of Bpi Protein Products For Human Meningococcemia

US Patent:

6596691, Jul 22, 2003

Filed:

Nov 30, 2000

Appl. No.:

09/728938

Inventors:

Brett P. Giroir - Dallas TX
Patrick J. Scannon - San Francisco CA

Assignee:

XOMA Corporation - Berkeley CA

International Classification:

A61K 3800

US Classification:

514 12, 514 21, 514898, 530324, 530350, 530829, 530830, 424529, 424534

Abstract:

Methods and materials for the treatment of human meningococcemia are provided in which therapeutically effective amounts of BPI protein products are administered.

Therapeutic Uses Of Bpi Protein Products For Human Meningococcemia

US Patent:

6242418, Jun 5, 2001

Filed:

Aug 3, 1999

Appl. No.:

9/365858

Inventors:

Brett P. Giroir - Dallas TX
Patrick J. Scannon - San Francisco CA

Assignee:

Xoma Corporation - Berkeley CA
The Board of Regents, The University of Texas System - Austin TX

International Classification:

A61K 3800, A61K 3514

US Classification:

514 12

Abstract:

Methods and materials for the treatment of human meningococcemia are provided in which therapeutically effective amounts of BPI protein products are administered.

Therapeutic Uses Of Bpi Protein Products For Human Meningococcemia

US Patent:

5990086, Nov 23, 1999

Filed:

Dec 1, 1998

Appl. No.:

9/203159

Inventors:

Brett P. Giroir - Dallas TX
Patrick J. Scannon - San Francisco CA

Assignee:

Xoma Corporation - Berkeley CA

International Classification:

A61K 3800, A61K 3514

US Classification:

514 12

Abstract:

Methods and materials for the treatment of human meningococcemia are provided in which therapeutically effective amounts of BPI protein products are administered.

Therapeutic Uses Of Bpi Protein Products For Human Meningococcemia

US Patent:

5888977, Mar 30, 1999

Filed:

Sep 10, 1997

Appl. No.:

8/927437

Inventors:

Brett P. Giroir - Dallas TX
Patrick J. Scannon - San Francisco CA

International Classification:

A61K 3800, A61K 3514

US Classification:

514 12

Abstract:

Methods and materials for the treatment of human meningococcemia are provided in which therapeutically effective amounts of BPI protein products are administered.